We are live on
!
Find out more
TCM
Tygh Capital Management Portfolio holdings
AUM
$782M
1-Year Est. Return
39.44%
This Fund
S&P 500
This Quarter
Est. Return
+9.49%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
–
AUM
$782M
AUM Growth
+$42.5M
(+5.8%)
Cap. Flow
-$4.75M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
25.12%
Holding
97
New
10
Increased
43
Reduced
34
Closed
10
Top Buys
| 1 |
HEES
H&E Equipment Services
HEES
|
+$11.9M |
| 2 |
Hannon Armstrong Sustainable Infrastructure Capital
HASI
|
+$11.6M |
| 3 |
Kontoor Brands
KTB
|
+$9.55M |
| 4 |
LHCG
LHC Group LLC
LHCG
|
+$7.26M |
| 5 |
Lindblad Expeditions
LIND
|
+$6.65M |
Top Sells
| 1 |
Commault Systems
CVLT
|
+$10.9M |
| 2 |
Casella Waste Systems
CWST
|
+$7.74M |
| 3 |
NeoGenomics
NEO
|
+$7.7M |
| 4 |
HealthEquity
HQY
|
+$7.62M |
| 5 |
Pennant Group
PNTG
|
+$7.59M |
Sector Composition
| 1 | Technology | 32.37% |
| 2 | Industrials | 21.74% |
| 3 | Consumer Discretionary | 17.88% |
| 4 | Healthcare | 15.42% |
| 5 | Financials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alkermes
ALKS
$8.66B
| $2.28M | 0.29% |
98,069
-196
| -0.2% | -$5.15K |
|
77
Twist Bioscience
TWST
$5.68B
| $2.16M | 0.28% |
27,912
-55
| -0.2% | -$5.64K |
|
78
PTC Therapeutics
PTCT
$6.51B
| $1.85M | 0.24% |
46,372
-100
| -0.2% | -$3.83K |
|
79
Beam Therapeutics
BEAM
$2.92B
| $1.82M | 0.23% |
22,899
-44
| -0.2% | -$3.77K |
|
|
APLS
80
DELISTED
Apellis Pharmaceuticals
APLS
| $1.77M | 0.23% |
37,542
-75
| -0.2% | -$2.95K |
|
81
TG Therapeutics
TGTX
$8.41B
| $1.48M | 0.19% |
78,113
-155
| -0.2% | -$4.02K |
|
82
CareDx
CDNA
$2.08B
| $1.18M | 0.15% |
25,831
-4,889
| -16% | -$255K |
|
83
iShares Russell 2000 Growth ETF
IWO
$14.8B
| $901K | 0.12% |
+3,076
| New | +$927K |
|
84
Kaiser Aluminum
KALU
$2.62B
| $880K | 0.11% |
9,367
-58,592
| -86% | -$5.93M |
|
85
BridgeBio Pharma
BBIO
$15.7B
| $715K | 0.09% |
42,848
-86
| -0.2% | -$3.64K |
|
|
86
HealthEquity
HQY
$8.25B
| $588K | 0.08% |
13,300
-130,838
| -91% | -$7.62M |
|
87
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.29B
| $238K | 0.03% |
+1,716
| New | +$234K |
|
88
Byrna Technologies
BYRN
$77.2M
| – | – |
-229,292
| Closed | -$5.01M |
|
89
Cardlytics
CDLX
$24M
| – | – |
-4,143
| Closed | -$3.48M |
|
90
Charles River Laboratories
CRL
$11B
| – | – |
-16,374
| Closed | -$6.76M |
|
|
91
Commault Systems
CVLT
$6.2B
| – | – |
-144,685
| Closed | -$10.9M |
|
92
Kratos Defense & Security Solutions
KTOS
$8.81B
| – | – |
-335,526
| Closed | -$7.49M |
|
93
nCino
NCNO
$1.99B
| – | – |
-88,272
| Closed | -$6.27M |
|
|
94
NeoGenomics
NEO
$1.93B
| – | – |
-159,678
| Closed | -$7.7M |
|
|
95
Pennant Group
PNTG
$1.45B
| – | – |
-270,182
| Closed | -$7.59M |
|
96
Telos
TLS
$354M
| – | – |
-159,549
| Closed | -$4.53M |
|
|
DMTK
97
DELISTED
DermTech, Inc. Common Stock
DMTK
| – | – |
-155,754
| Closed | -$5M |
|
Similar funds
IVP
FMBTD
EHPM
VMV
SIM
HAM
VIMU
AC